Petros Pharmaceuticals, Inc.: Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy
Data Published in the "International Journal of Urology" Also Showed Secondary Endpoints, Such as Onset of action in 15 Minutes and Percentage of Patients Reaching Normal Erectile Function According to